NHI SVP Legal Files Initial Form 3

National Health Investors Inc. reported that Elizabeth Jackson Blankenship, who serves as Senior Vice President of Legal Affairs, has filed an initial statement of beneficial ownership of the company’s securities on Form 3 as an officer.

Accepted by SEC EDGAR 03/04/2026 - 07:33 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

National Health Investors Inc. reported that Elizabeth Jackson Blankenship, who serves as Senior Vice President of Legal Affairs, has filed an initial statement of beneficial ownership of the company’s securities on Form 3 as an officer. The filing does not list any reportable transactions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the new Form 3 for NHI indicate about Elizabeth Jackson Blankenship?

The Form 3 shows that Elizabeth Jackson Blankenship is a reporting person for National Health Investors Inc. (NHI). She is identified as an officer, serving as SVP, Legal Affairs, and is now subject to ongoing insider reporting requirements.

Did the NHI Form 3 filing report any stock transactions by Elizabeth Jackson Blankenship?

The Form 3 for National Health Investors Inc. (NHI) does not report any stock transactions for Elizabeth Jackson Blankenship. The transaction summary shows zero buys, zero sells, and no other types of reportable transactions in this initial ownership statement.

What is Elizabeth Jackson Blankenship’s role at National Health Investors Inc. (NHI)?

Elizabeth Jackson Blankenship is listed as an officer of National Health Investors Inc. (NHI) with the title SVP, Legal Affairs. This senior leadership position is the basis for her status as a reporting person under insider ownership rules.

Does the NHI Form 3 show Elizabeth Jackson Blankenship as a 10% owner?

The Form 3 indicates that Elizabeth Jackson Blankenship is not a ten percent owner of National Health Investors Inc. (NHI). She is instead classified as an officer reporting person, reflecting her executive role rather than large ownership status.

What does a neutral net buy/sell direction mean in NHI’s Form 3 summary?

The transaction summary for National Health Investors Inc. (NHI) shows a neutral net buy/sell direction. This reflects that there were no reported purchases, sales, acquisitions, or dispositions associated with Elizabeth Jackson Blankenship in this initial Form 3 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Blankenship Elizabeth Jackson

(Last) (First) (Middle)

222 ROBERT ROSE DR

(Street)

MURFREESBORO TN 37129

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/17/2026

3. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Legal Affairs

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Kimberly V. Ouimet, by limited power of attorney	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.